is supported by a Novo Nordisk Foundation Center for Basic Metabolic Research International PhD Fellowship
The GLP-1 hormone is rapidly inactivated by the enzyme DPP-4, with a half-life of only 12 min
We extracted genomic data, EHR data and a drug code referring to either semaglutide or tirzepatide from 9,579 participants
The compound is currently in the development pipeline, with Eli Lilly, the pharmaceutical company behind its creation, actively pursuing the next stages of the regulatory process
All products are for laboratory research use only
3DLOOK has introduced FitXpress, a weight loss tech that employs cutting-edge body scanning technology to provide users with detailed body measurements and personalized fitness insights